Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that ...

Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...

Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...

Marking International Women’s Day, The Independent has compiled its annual list of the 50 most influential women across the ...

As public health officials warn about rising emissions from urban wood burning, a BMJ investigation finds that just under a ...

Morris, Nada Hassanein, Shalina Chatlani and Sofia Resnick, Wisconsin Examiner March 4, 2026 Editor’s note: This is ...

Natera, Inc. (NTRA) 47th Annual Raymond James Institutional Investor Conference March 4, 2026 1:05 PM ESTCompany ParticipantsMike Brophy - Chief ...

The end of the 1970s seemed to be a moment of uncertainty for Don DeLillo, creatively speaking. The previous decade had seen ...

Cryogenic microscopy at Diamond Light Source enables high-resolution, correlative imaging of cells under near-physiological ...

Somalia is on the brink of a deepening humanitarian crisis, with an estimated 6.5 million people facing acute food insecurity ...